Ocular Surface Disease
An Introduction to Ocular Surface Disease
Ocular surface disease is a prevalent condition, and with the increasing use of screens and monitors, this trend is likely to continue. Treatment options include artificial tears and gels, short courses of corticosteroids and prescription drugs cyclosporine 0.05% and lifitegrast 5%. Several devices have recently been introduced that help to relieve meibomian gland congestion and offer an alternative treatment.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Ocular Surface Disease Content
Jennifer Loh: ASCRS 2020 – A Novel, Targeted, Open Eye, Thermal Therapy for Treatment of Dry Eye
Jennifer Loh (South Florida Vision Associates, Fort Lauderdale, Florida, USA) discusses unmet needs in the treatment of dry eye, and gives an overview of the TearCare system and the efficacy and safety findings of the OLYMPIA clinical trial. Questions: 1. What are the major unmet needs in the treatment of dry eye? (0:12) 2. Could […]
Hot Topics – How to minimise eye drop burden postoperatively
Cynthia Matossian discusses the latest technological and pharmaceutical advancements that are easing the burden of administering eye drops, both for patients and their caregivers.
Hot Topics – Treatment options for meibomian gland dysfunction include intense pulsed light, what is it?
Cynthia Matossian discusses intense pulsed light (IPL), a new treatment for meibomian gland dysfunction, which is one of the causes of dry eye disease.
Hot Topics – What procedures and tools are used to treat meibomian gland dysfunction?
Cynthia Matossian discusses the procedures and tools that are currently available to treat dry eye disease associated with meibomian gland dysfunction, including LipiFlow® from Johnson and Johnson, TearCare® (Sight Sciences), and EyeLocks from Alcon.
Hot Topics – What pharmaceutical products beat dry eye disease?
Cynthia Matossian discusses some of the new pharmaceutical products that are available for dry eye disease, including Restasis®, XiidraTM (lifitegrast), CequaTM (cyclosporine), and Klarity-C Drops® that are available on prescription when dry eye disease patients present with inflammation.
Dry Eye – Can You Cry?
European Ophthalmic Review. 2019;13(2):81–6
Sex, Gender and Hormones in Dry Eye Disease
European Ophthalmic Review, 2019;13(2):63–4
Dry Eye in Video Display Terminal Users
European Ophthalmic Review. 2019;13(2):67–8
Dry eye is a common ocular condition that results in eye pain and discomfort, visual disturbance and substantially affects quality of life.1 The incidence of dry eye is markedly increasing due to the expansion in the global internet network.2 The use of video display terminals (VDT) and other devices, including desktops, laptops, tablets, and smartphones is now […]
Efficacy and Safety of Topical Cyclosporine in Dry Eye Subjects Who Engage in Electronic Visual Tasking—The EMPOWER Study
US Ophthalmic Review. 2019;12(2):88–95
Introduction In the recently updated Dry Eye WorkShop DEWS II report, dry eye is defined as a multifactorial disease of the ocular surface characterized by loss of homeostasis of the tear film, accompanied by ocular symptoms, tear film instability, hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities.1 Chronic, T cell–mediated inflammation of the ocular surface […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!